Market open· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

A failed colorectal cancer trial and weaker sales outlook weigh on BioNTech, while new lung cancer data offer a counterpoint.

The banks are studying how digital Canadian-dollar deposits might move between institutions, but no customer launch has been announced.